105 related articles for article (PubMed ID: 762813)
21. Methyldopa and propranolol in moderate hypertension.
Agarwal RK; Bhatnagar MK; Shukla SK; Gupta R; Dwivedi RN
Indian Heart J; 1980; 32(1):13-5. PubMed ID: 7380450
[No Abstract] [Full Text] [Related]
22. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
McMahon FG
JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
[TBL] [Abstract][Full Text] [Related]
23. Low doses v standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone.
JAMA; 1982 Nov; 248(19):2471-7. PubMed ID: 6752448
[TBL] [Abstract][Full Text] [Related]
24. The treatment of chronic hypertension.
Gilmore HR
Med Clin North Am; 1971 Mar; 55(2):317-24. PubMed ID: 4396018
[No Abstract] [Full Text] [Related]
25. Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in Black and Indian hypertensive patients.
Seedat YK; Hoosen S; Bhigjee AI
S Afr Med J; 1984 Jun; 65(23):915-7. PubMed ID: 6374931
[TBL] [Abstract][Full Text] [Related]
26. Severe hypertension and haemospermia--a case report.
Awotedu AA
West Afr J Med; 1989; 8(1):89-90. PubMed ID: 2486779
[TBL] [Abstract][Full Text] [Related]
27. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group.
Schoenberger JA; Croog SH; Sudilovsky A; Levine S; Baume RM
Am J Hypertens; 1990 Feb; 3(2):123-32. PubMed ID: 2407265
[TBL] [Abstract][Full Text] [Related]
28. Oral thiazide diuretics in the treatment of hypertension in Nigeria.
Salako LA
West Afr Med J Niger Pract; 1971 Oct; 20(5):320-3. PubMed ID: 5136799
[No Abstract] [Full Text] [Related]
29. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
30. Methyldopa and propranolol or practolol in moderate hypertension.
Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
[TBL] [Abstract][Full Text] [Related]
31. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
32. [Quantitative determination of the efficacy of antihypertensive agent combinations].
Stoepel K; Kaller H; Kroneberg G
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):189-96. PubMed ID: 4239710
[No Abstract] [Full Text] [Related]
33. [Condition of the contractile capacity of the myocardium in treatment of hypertensive disease with reserpine in combination with propranolol].
Komarov FI; Felechko FN; Ostrovskaia VI; Mytareva IL
Kardiologiia; 1975 Apr; 15(4):145-6. PubMed ID: 1142626
[No Abstract] [Full Text] [Related]
34. The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
Murphy JE
J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542
[TBL] [Abstract][Full Text] [Related]
35. [Dose-effect comparison of antihypertensive combinations with and without alpha-methyldopa].
Krämer KD; Ghabussi P; Lehmann HU; Hochrein H
MMW Munch Med Wochenschr; 1975 Apr; 117(14):579-82. PubMed ID: 806789
[TBL] [Abstract][Full Text] [Related]
36. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
Fernandez PG; Kim BK; Galway AB
Pharmatherapeutica; 1984; 3(8):505-14. PubMed ID: 6322207
[TBL] [Abstract][Full Text] [Related]
37. Lowering blood pressure in the aged: a 40-month experience.
Schnapp P
Gerontology; 1984; 30(1):55-9. PubMed ID: 6421657
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.
Ogola EN; Yonga GO
East Afr Med J; 1993 May; 70(5):277-9. PubMed ID: 8306902
[TBL] [Abstract][Full Text] [Related]
39. Treatment of resistant hypertension: 3 years of follow-up with the combination of verapamil and methyldopa.
Spritzer N; Spritzer TS; Rodrigues R
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S65-7. PubMed ID: 2475692
[TBL] [Abstract][Full Text] [Related]
40. Methyldopa: single daily dose versus multiple daily dose.
Yang C; Gurwich E; Kanada S; Nascimento L
Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
